Navigation Links
Bees help to beat MRSA bugs
Date:6/28/2010

Bees could have a key role to play in urgently-needed new treatments to fight the virulent MRSA bug, according to research led at the University of Strathclyde in Glasgow, Scotland.

The scientists found that a substance known as beeglue or propolis, originating from beehives in the Pacific region, was active against MRSA, which causes potentially fatal infections, particularly in hospital patients.

The bug was either the underlying cause or a contributory factor in more than 1,900 deaths between 1996 and 2008.

The research, published in Phytotherapy Research journal, is an example of the pioneering work of the Strathclyde Institute of Pharmacy and Biomedical Sciences in developing new medicines for illnesses and conditions including infectious diseases, cancer, heart disease, and schizophrenia. An 8 million fundraising campaign is underway for the Institute's new 36 million building, to expand and enhance its innovative research and education in medicine discovery, development and use.

Dr Vronique Seidel, a Lecturer in Natural Products Chemistry at the Institute, led the research. She said: "MRSA can have a devastating impact on people who contract it and on their families, often compounding illnesses they already have.

"One of the few available drugs to treat MRSA infections is an antibiotic called vancomycin. But new strains have been emerging which show limited susceptibility, or even resistance, to vancomycin.

"This means that there is a pressing need to discover and develop alternatives to current anti-MRSA drugs. We investigated propolis, as part of a programme aimed at discovering new antibiotics from natural sources, because bees use it as an antiseptic glue to seal gaps between honeycombs and preserve their hives from microbial contamination.

"Beeglue is also a natural remedy widely-used in folk medicine for a variety of ailments but little has been known until now about its capacity to target MRSA. Our results have been highly encouraging and we will be taking our research further to understand how active substances in propolis work and to seek the treatments which patients urgently require."

The Strathclyde researchers have been working in partnership with Nature's Laboratory in North Yorkshire, England, a world leader in propolis research and campaigner for deeper scientific understanding of natural medicines. They tested extracts of propolis on 15 MRSA strains obtained from the NHS and isolated two compounds, Propolin C and Propolin D, which showed good activity against all the MRSA strains tested.

The research is the first to report anti-MRSA activity in propolis originating from the Pacific region and the first to describe the anti-MRSA properties of Propolin C and Propolin D. These could possibly act as templates for the development of improved anti-MRSA agents.


'/>"/>

Contact: Paul Gallagher
paul.gallagher@strath.ac.uk
44-141-548-2370
University of Strathclyde
Source:Eurekalert

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... billion by 2021 from $8.3 billion in 2016 at ... 2016 to 2021. Report Includes - An overview ... global market trends, with data from 2015 and 2016, ... 2021. - Segmentation of the market on the basis ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/6/2017)... 2017 According to Acuity Market Intelligence, ... authorities to continue to embrace biometric and digital ... Automated Border Control (ABC) eGates and 1436 Automated ... than 163 ports of entry across the globe. ... a combined CAGR of 37%. APC Kiosks reached ...
Breaking Biology News(10 mins):
(Date:2/18/2017)... ... February 17, 2017 , ... A leader in ... Kong. , Nerium International is proud to introduce its Age-Defying Night Cream, NeriumAD™ ... Formula to consumers across Hong Kong. The luxury skincare products contain innovative ingredients ...
(Date:2/17/2017)... IPSWICH, Mass. , Feb. 17, 2017 /PRNewswire/ ... a small tumor had a mutation-conferring resistance to ... treatment. Recently, genomics research has focused on finding ... — or even from circulating tumor DNA in ... identify new oncology therapeutics. Unfortunately, however, ...
(Date:2/16/2017)... , ... February 16, 2017 , ... Avomeen & MichBio ... The event will be held at Avomeen Analytical Services (4840 Venture Dr., Ann Arbor, ... member organization. They provide an opportunity to interact with peers, make new connections and ...
(Date:2/16/2017)... Feb. 16, 2017  ArmaGen, Inc., a privately ... to treat severe neurological disorders, today reported preliminary ... AGT-181, the company,s investigational therapy for the treatment ... mucopolysaccharidosis type I, or MPS I). The initial ... study, presented today at the 13 th ...
Breaking Biology Technology: